Sally Snyder

Statistics

Publications

Citations

1.7K

H-Index

Active since

1975

Affiliations

Social and Scientific Systems (United States)(Current)

Harvard University

University of North Carolina at Chapel Hill

Cornell University

National Institute of Allergy and Infectious Diseases

Sally Snyder is an author at Social and Scientific Systems (United States) specializing in antiretroviral therapy, antiviral therapy, and antiviral pharmacology.

ORCID

Publications per year

1975–2007

Publications

Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection

Roy M. Gulick, Heather J. Ribaudo, Cecilia M. Shikuma et al. · New England Journal of Medicine · 2004 · 528 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection

Gregory K. Robbins, Victor De Gruttola, Robert W. Shafer et al. · New England Journal of Medicine · 2003 · 354 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Comparison of Four-Drug Regimens and Pairs of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection

Robert W. Shafer, Laura Smeaton, Gregory K. Robbins et al. · New England Journal of Medicine · 2003 · 231 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides

Michael P. Dubé, Robert A. Parker, Pablo Tebas et al. · AIDS · 2005 · 189 citations

Medicine, Pharmacology, Pharmacotherapy +17

Multiple-Dose Escalation Study of the Safety, Pharmacokinetics, and Biologic Activity of Oral AMD070, a Selective CXCR4 Receptor Inhibitor, in Human Subjects

Nimalie D. Stone, Shelia B. Dunaway, Charles Flexner et al. · Antimicrobial Agents and Chemotherapy · 2007 · 124 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

1–5 of 14